EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting PI3K/Akt/mTOR Pathway, Ki-67 and Endothelin Receptors by Ambrisentan in Juvenile Rat Intestinal Ischemia

Marwa Monier Mahmoud Refaie, Hanaa Hassanein Mohammed, Asmaa A Hasan iD, Sayed Shehata, Asmaa A Muhammed iD, Mohamad Assayed Nader iD, Zamzam M Abdelsamie, Hoda S Sherkawy, Enas Fathy, Shereen Mohammed Mohammed Elsaghir, Fatma F Ali, Ahmed M Ashour iD und 2 weitere

International Journal of Molecular Sciences · 14.06.2026 · 27 (12) · 5370

DOI: 10.3390/ijms27125370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.06.2026. Verfasst von Marwa Monier Mahmoud Refaie und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Minia University, Minia 61511, Egypt. Hauptthemen laut MEDLINE: Signal Transduction, Ki-67 Antigen, Receptors, Endothelin, Phenylpropionates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Umm al-Qura University, Umm Al-Qura University, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Juvenile intestinal ischemia–reperfusion (JII/R) is a pediatric surgical emergency caused by mesenteric vessel occlusion and has a high mortality rate. Malrotation can cause intestinal ischemia in infants due to midgut volvulus. It affects not only the intestine itself but also other organs, such as cardiac tissue. Therefore, searching for more effective therapeutic solutions is an essential critical need. This directed our thoughts to evaluate the role of ambrisentan (AMB) in a rat model of induced JII/R by clamping the superior mesenteric artery. Forty juvenile male Wistar albino rats (3–4 weeks old) were randomly divided into four experimental groups: control (CON) group, JII/R group, and AMB-treated groups (30, 60 mg/kg) with JII/R. Induction of JII/R results in significant changes in cardiac enzymes, oxidative stress, inflammatory, and apoptotic parameters with high expression of endothelin receptor A (ERA). Also, histopathological changes revealed extensive mucosal damage, loss of intestinal villi, dysregulated and degenerated cardiac fibers with inflammatory cell infiltration, and tissue necrosis. In contrast, AMB administration significantly reduced the elevated levels of cardiac enzymes, malondialdehyde (MDA), nuclear factor kappa B (NF-κB), ERA, and caspase-3 expression. However, AMB treatment increased immune expressions of phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt), Ki-67, and mammalian target of rapamycin (mTOR) and showed remarkable improvement in the histopathological changes. AMB could be considered as an adjuvant medical treatment for cases of JII/R.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionKi-67 AntigenReceptors, EndothelinPhenylpropionatesPyridazinesIschemiaAgingMaleAnimalsRatsRats, WistarOxidative StressIntestinal DiseasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesReperfusion InjuryPhosphorylation

Stichwörter der Autor:innen

ambrisentanendothelinintestinal ischemia–reperfusionprotein kinase B

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesKi-67 AntigenMKi67 protein, ratReceptors, EndothelinambrisentanPhenylpropionatesPyridazines

Autor:innen und Institutionen

  • Department of Medical Pharmacology, Faculty of Medicine, Minia University, Minia 61511, Egypt.
  • Faculty of Medicine, Minia National University, New Minia 61768, Egypt.
  • Department of Histology and Cell Biology, Faculty of Medicine, Minia University, Minia 61511, Egypt.
  • Department of Human Anatomy and Embryology, Faculty of Medicine, Aswan University, Aswan 81528, Egypt.
  • Department of Cardiology, Faculty of Medicine, Minia University, Minia 61511, Egypt.
  • Department of Medical Physiology, Faculty of Medicine, Aswan University, Aswan 81528, Egypt.

ORCID-Profile: Asmaa A Hasan, Asmaa A Muhammed, Mohamad Assayed Nader, Ahmed M Ashour, Doaa Mohamed Elroby Ali

Förderung

  • Umm al-Qura University
  • Umm Al-Qura University, Saudi Arabia

Zitieren

APA

Refaie, M. M. M., Mohammed, H. H., Hasan, A. A., Shehata, S., A Muhammed, A., Nader, M. A., Abdelsamie, Z. M., Sherkawy, H. S., Fathy, E., Elsaghir, S. M. M., Ali, F. F., Ashour, A. M., Khames, A., & Mohamed Elroby Ali, D. (2026). Targeting PI3K/Akt/mTOR Pathway, Ki-67 and Endothelin Receptors by Ambrisentan in Juvenile Rat Intestinal Ischemia. International Journal of Molecular Sciences, 27(12), 5370. https://doi.org/10.3390/ijms27125370

Vancouver

Refaie MMM, Mohammed HH, Hasan AA, Shehata S, A Muhammed A, Nader MA, et al. Targeting PI3K/Akt/mTOR Pathway, Ki-67 and Endothelin Receptors by Ambrisentan in Juvenile Rat Intestinal Ischemia. International Journal of Molecular Sciences. 2026;27(12):5370. doi:10.3390/ijms27125370

BibTeX
@article{Refaie2026,
  author = {Refaie, Marwa Monier Mahmoud and Mohammed, Hanaa Hassanein and Hasan, Asmaa A and Shehata, Sayed and A Muhammed, Asmaa and Nader, Mohamad Assayed and Abdelsamie, Zamzam M and Sherkawy, Hoda S and Fathy, Enas and Elsaghir, Shereen Mohammed Mohammed and Ali, Fatma F and Ashour, Ahmed M and Khames, Ali and Mohamed Elroby Ali, Doaa},
  title = {Targeting PI3K/Akt/mTOR Pathway, Ki-67 and Endothelin Receptors by Ambrisentan in Juvenile Rat Intestinal Ischemia},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5370},
  doi = {10.3390/ijms27125370}
}
Kostenlos starten →